Teva, Sanofi present new results from RELIEVE UCCD Phase 2b study
Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 ...
The Pharma Letter16h
The week in pharma: action, reaction and insight – week to February 21
Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...
IEUR: European Equities Are Going To Be Great Again!
IEUR's holdings include Europe's innovative GRANOLAS and Germany's Mag7, providing a strong backbone and momentum for the ETF. Read why IEUR is a Strong Buy.